Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharma | Vienna | Salute | Ricerca medica e biotecnologica | 113,94 Mrd € | -253,6x | 2,21 | 435,35 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regeneron Pharma | Vienna | Salute | Ricerca medica e biotecnologica | 100,75 Mrd € | 25,2x | 921,40 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
IQVIA Holdings | Vienna | Salute | Ricerca medica e biotecnologica | 38,60 Mrd € | 29,7x | 0,9 | 211,70 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
argenx SE | Vienna | Salute | Ricerca medica e biotecnologica | 29,52 Mrd € | -157,7x | -3,02 | 479,20 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioNTech SE DRC | Vienna | Salute | Ricerca medica e biotecnologica | 26,17 Mrd € | -52,2x | 0,47 | 111 € | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Moderna | Vienna | Salute | Ricerca medica e biotecnologica | 20,40 Mrd € | -3,8x | 0,01 | 53,38 € | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genmab AS | Vienna | Salute | Ricerca medica e biotecnologica | 13,68 Mrd € | 18,9x | 0,92 | 216,80 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Qiagen | Vienna | Salute | Ricerca medica e biotecnologica | 8,93 Mrd € | 134,2x | -1,71 | 40,06 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Galapagos NV | Vienna | Salute | Ricerca medica e biotecnologica | 1,78 Mrd € | 6,3x | 0,2 | 26,74 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Evotec | Vienna | Salute | Ricerca medica e biotecnologica | 947,69 Mln € | -5,6x | 0,09 | 5,64 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CureVac NV | Vienna | Salute | Ricerca medica e biotecnologica | 587,03 Mln € | -2,1x | -0,14 | 2,64 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Valneva | Vienna | Salute | Ricerca medica e biotecnologica | 414,14 Mln € | -10,8x | 0,04 | 2,58 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medigene | Vienna | Salute | Ricerca medica e biotecnologica | 27,24 Mln € | -1,5x | -0,04 | 1,89 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |